https://doi.org/10.1177/20499361211046086

">
 

Document Type

Article

Abstract

Chagas disease (CD), caused by the protozoan Trypanosoma cruzi, is a public health concern, mainly among countries in South and Central America. However, despite the large number of immigrants from endemic countries living in the USA, awareness of CD is poor in the medical community, and therefore it is significantly underdiagnosed. To avoid the catastrophic cardiac complications of CD and to prevent maternal–fetal transmission, widespread educational programs highlighting the need for diagnosis are urgently needed.

Digital Object Identifier (DOI)

https://doi.org/10.1177/20499361211046086

APA Citation

Marcus, R., Henao-Martínez, A. F., Nolan, M., Livingston, E., Klotz, S. A., Gilman, R. H., Miranda-Schaeubinger, M., & Meymandi, S. (2021). Recognition and screening for Chagas disease in the USA. Therapeutic Advances in Infectious Disease, 8. https://doi.org/10.1177/20499361211046086

Share

COinS